Assembly Biosciences (ASMB) Stock: Buy, Sell, or Hold?
$20.00
-2.37 (-10.59%)
âŧ
5d:
+0.0%
30d:
-2.58%
90d:
-39.3%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
40/100
Position
SLIGHTLY LOW
30-Day Fair Range
$19.79 â $22.09
Position: SLIGHTLY LOW
Forward P/E & Valuation
-8.7x
Next 12M consensus est.
Wall Street Target
$51.20
+128.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$19.20 / $22.69
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: ASMB is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When ASMB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ASMB is currently trading at $20.00, which is considered slightly low relative to its 30-day fair value range of $19.79 to $22.09.
Technical Outlook: Technically, ASMB is in a downtrend. Immediate support is located at $19.20, while resistance sits at $22.69. Short-term momentum is weak, with the stock down 10.6% recently.
Market Sentiment: ASMB scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $51.20 (+128.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ASMB is in a downtrend. Immediate support is located at $19.20, while resistance sits at $22.69. Short-term momentum is weak, with the stock down 10.6% recently.
Market Sentiment: ASMB scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $51.20 (+128.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$19.79 -
$22.09
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$19.79 -
$22.09
Current vs Trading Range
SLIGHTLY LOW
Support Level
$19.20
Resistance Level
$22.69
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.6%)
- BULLISH: Trading 128.9% below Wall St target ($51.20)
- WARNING: Composite score 40/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-8.69
Wall Street Target
$51.20
(+128.9%)
Revenue Growth (YoY)
38.9%
Profit Margin
-0.1%
Share ASMB Analysis
Share this live ASMB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ASMB)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message highlights $ASMB's progress in phase 2 trials and anticipates further upward movement in the stock price, with a potential acquisition being a possibility. No recent news articles were available.
Key Retail Themes:
clinical trial progress
potential acquisition
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:59 PM ET
Data refreshes hourly during market hours. Next update: 2:59 PM
Data refreshes hourly during market hours. Next update: 2:59 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ASMB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$978 | 32 SELL |
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ASMB Research Pages
